Carter's, Inc. Q4 2025 Earnings Call Summary - Moby Strategic Transformation and Performance Drivers Achieved first year-over-year revenue growth since 2021, driven by a third consecutive quarter of U.S. Retail comparable sales gains. Transitioning from purely transactional messaging to emotion-driven storytelling to build consumer loyalty and reduce reliance on heavy promotions. Successfully attracting higher-income Gen Z and millennial families who are opting for 'better and best' product tiers wi ...

Viatris (NasdaqGS:VTRS) Q4 2025 Earnings call February 26, 2026 08:30 AM ET Company ParticipantsAsh Verma - Executive Director, SMID Biotech and BiopharmaBill Szablewski - Head of Capital MarketsCorinne Le Goff - Chief Commercial OfficerDoretta Mistras - CFOPhilippe Martin - Chief R&D OfficerScott Smith - CEOUmer Raffat - Senior Managing DirectorConference Call ParticipantsChris Schott - Managing Director and Senior Equity Research AnalystDavid Amsellem - Managing Director, Senior Research AnalystDennis Din ...

Financial Data and Key Metrics Changes - In 2025, the company reported total revenues of $14.3 billion, representing approximately 2% growth compared to 2024, excluding the impact of the India pack [4][21] - Adjusted EBITDA for 2025 was $4.2 billion, with adjusted EPS of $2.35 per share and free cash flow of $2.2 billion, excluding transaction-related costs [21][22] - For Q4 2025, total revenues were $3.7 billion, up 1% year-over-year, excluding the indoor impact [20] Business Line Data and Key Metrics Changes - The company achieved strong commercial performance across its global portfolio, with significant contributions from its cardiovascular portfolio in Greater China and competitive strength in Europe and emerging markets [20][21] - New product revenues are anticipated to contribute $450 million to $550 million in 2026, with growth expected in developed markets and emerging markets [23][24] Market Data and Key Metrics Changes - In Greater China, the company expects 3% year-over-year growth, driven primarily by cardiovascular products [25] - Emerging markets are projected to grow 6% year-over-year, supported by expansion in key markets like Turkey, Mexico, India, and Brazil [24] Company Strategy and Development Direction - The company aims to drive its base business through successful product launches and evolving its generics portfolio towards higher-margin products [6][7] - Strategic imperatives include fueling the innovative portfolio with late-stage and in-market growth assets, and modernizing operations for sustainable growth [6][7] - The company plans to deliver approximately $650 million in gross cost savings over three years, with $250 million earmarked for reinvestment in growth areas [5][22] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in entering a period of long-term sustainable growth beginning in 2026, with a focus on strong financial performance and commercial execution [4][8] - The company anticipates regulatory decisions for several product candidates in 2026, which are expected to support future performance [8][11] Other Important Information - A fire incident at the Nashik, India facility has temporarily suspended manufacturing, with operations expected to resume in April [26] - The company is focused on returning the JANZ segment to growth while managing pricing headwinds in certain Asian markets [24][25] Q&A Session Summary Question: Path to mid-single-digit revenue growth and confidence in approvals - Management indicated that the path to mid-single-digit growth involves a growing base business and upcoming product launches, with confidence in the six potential approvals this year [32][34] Question: Breakdown of $650 million savings and timing - The savings are expected to be phased over three years, with approximately 30% in 2026, 30% in 2027, and 40% in 2028 [33][38] Question: Cost cuts and India recovery assumptions - About 50% of the $650 million savings will come from headcount reductions, with less than 1% of India recovery included in the 2026 guidance [40][43] Question: Restructuring charges versus net savings - The company estimates that the one-time costs to achieve savings will be about 1 times the gross savings, with $250 million expected this year [47][49] Question: Fast-acting meloxicam market focus - The initial focus for fast-acting meloxicam will be on post-operative and operative acute pain management, targeting specialty physicians [52][54] Question: Regulatory pricing challenges in Japan - Japan faces mandatory price decreases impacting revenue and EBITDA, but new assets are expected to turn the business towards growth by 2028 [56][58]

Teleflex (NYSE:TFX) Q4 2025 Earnings call February 26, 2026 08:00 AM ET Company ParticipantsBradley Bowers - VP of Equity ResearchJayson Bedford - Managing Director of Equity ResearchJohn Deren - EVP and CFOLawrence Keusch - Vice President of Investor Relations and Strategy DevelopmentStuart Randle - Interim President and CEOTravis Steed - Managing Director of Medical Technology Equity ResearchConference Call ParticipantsLarry Biegelsen - Senior Medical Device Equity Research AnalystMatthew O'Brien - Managi ...

Teleflex (NYSE:TFX) Q4 2025 Earnings call February 26, 2026 08:00 AM ET Company ParticipantsBradley Bowers - VP of Equity ResearchJayson Bedford - Managing Director of Equity ResearchJohn Deren - EVP and CFOLawrence Keusch - Vice President of Investor Relations and Strategy DevelopmentStuart Randle - Interim President and CEOTravis Steed - Managing Director of Medical Technology Equity ResearchConference Call ParticipantsLarry Biegelsen - Senior Medical Device Equity Research AnalystMatthew O'Brien - Managi ...

Financial Data and Key Metrics Changes - In Q4 2025, Westlake reported a net loss of $33 million, or a loss of $0.25 per share, on sales of $2.5 billion, which was a $5 million lower loss compared to Q3 2025 due to lower average sales prices and sales volumes [14][15] - For the full year 2025, net loss was $116 million, with EBITDA of $1.1 billion, and total sales of $11.2 billion, reflecting an 8% decline year-over-year [15][16] - The company achieved $170 million in structural cost reductions in 2025, with an additional $60 million in Q4 alone [15][21] Business Line Data and Key Metrics Changes - The Housing and Infrastructure Products (HIP) segment experienced an 8% decline in sales year-over-year in Q4, primarily due to decreased sales volumes in PVC compounds and exterior building products, although municipal pipe sales remained strong [17][19] - The Performance and Essential Materials (PEM) segment's Q4 EBITDA was $45 million, down from $90 million in Q3, driven by a 5% decline in average sales prices and a 2% decrease in sales volume [19][20] - For the full year 2025, PEM's EBITDA was $267 million, significantly lower than in 2024 due to higher feedstock and energy costs, as well as lower global sales prices [20] Market Data and Key Metrics Changes - The company noted global overcapacity in certain products, particularly in polyethylene and core vinyls, which pressured sales prices and margins throughout 2025 [20] - The forecast for housing starts in 2026 is between 1.3 million and 1.4 million, with expectations for improved home affordability due to lower interest rates [22] Company Strategy and Development Direction - Westlake is implementing a three-pillar strategy expected to contribute $600 million in earnings improvement in 2026, focusing on footprint optimization, plant reliability, and structural cost reductions [10][12] - The company has closed several higher-cost PEM assets and is focusing on improving operational reliability to enhance profitability [11][20] - The acquisition of ACI is expected to expand product offerings and contribute positively to revenue growth in the HIP segment [22][86] Management's Comments on Operating Environment and Future Outlook - Management expressed cautious optimism for 2026, citing signs of improvement in global industrial and manufacturing activity and a rebound from seasonal lows [24][25] - The company aims to reduce carbon emissions intensity by 20% by 2030, having already achieved its previous emissions reduction goal six years early [25] - Management emphasized the importance of a diversified portfolio and a vertically integrated business model to navigate market challenges [25][26] Other Important Information - The Chief Financial Officer, Steve Bender, announced plans to retire later in 2026, with gratitude expressed for his contributions to the company [13][14] - Cash and securities as of December 31, 2025, were $2.9 billion, with total debt at $5.6 billion, indicating a well-positioned balance sheet [20][21] Q&A Session Summary Question: Can you break down the PEM business in Q4 and its performance? - The performance was impacted by the closure of core vinyl plants, leading to a reduction in losses and a proactive approach in cost reduction initiatives [30][32] Question: What are the expectations around polyethylene price increases? - There has been some improvement in demand and price action, with announced price increases expected to offset previous market adjustments [33][34] Question: What is the outlook for chlorovinyls and the PVC chain in 2026? - There is cautious optimism with some restocking observed, but visibility remains limited [38][39] Question: How will the $600 million in cost savings be realized throughout the year? - The savings will be realized through structural cost reductions and improved reliability, with benefits expected to accrue throughout 2026 [44][46] Question: What are the expectations for free cash flow in 2026? - The objective is to generate strong cash flows, with a focus on cost savings and improved reliability [58][60] Question: How does the company view the competitive landscape following recent changes in ownership of a competitor? - No significant changes in competition have been observed at this stage [67] Question: What is the outlook for domestic merchant chlorine? - Weakness in chlorine demand has been noted, driven by reduced demand in construction materials and water treatment [68][69] Question: How do the benefits from plant reliability and cost reduction relate to EBITDA? - The benefits will start to materialize in 2026, with a focus on cost initiatives and reduced planned outages [74][75]

Financial Data and Key Metrics Changes - In Q4 2025, the company reported a net loss of $33 million, or a loss of $0.25 per share, on sales of $2.5 billion, which was a $5 million lower loss compared to Q3 2025 [14][15] - For the full year 2025, the company reported a net loss of $116 million and EBITDA of $1.1 billion, with total sales declining 8% to $11.2 billion compared to 2024 [15][16] - The company achieved $170 million in structural cost reductions in 2025, with an additional $60 million in Q4 alone [15][21] Business Line Data and Key Metrics Changes - The Housing and Infrastructure Products (HIP) segment saw an 8% decline in sales year-over-year in Q4, primarily due to decreased sales volumes in PVC compounds and exterior building products [17][19] - The Performance and Essential Materials (PEM) segment's Q4 EBITDA was $45 million, down from $90 million in Q3, driven by a 5% decline in average sales prices and a 2% decrease in sales volume [19][20] - For the full year 2025, HIP's EBITDA was $839 million with a margin of 20%, while PEM's EBITDA was $267 million, significantly impacted by higher feedstock costs and global overcapacity [17][20] Market Data and Key Metrics Changes - The company noted a decline in new housing construction activity in North America, which negatively affected sales in the HIP segment [9][16] - Global overcapacity in certain products continued to exert downward pressure on sales prices in the PEM segment, leading to margin compression [10][20] - The company expects housing starts in 2026 to range between 1.3 million and 1.4 million, with improved home affordability due to lower interest rates [22][24] Company Strategy and Development Direction - The company is executing a three-pillar strategy aimed at achieving $600 million in earnings improvement in 2026 through footprint optimization, improved plant reliability, and additional cost reductions [10][12][21] - The company has closed several higher-cost PEM assets to reduce exposure to low-priced export markets, which is expected to yield a $100 million annual EBITDA benefit starting in 2026 [20][21] - The company remains focused on value creation and is strategically deploying its balance sheet to enhance long-term shareholder value [21][25] Management's Comments on Operating Environment and Future Outlook - Management expressed cautious optimism regarding signs of improvement in global industrial and manufacturing activity, with expectations for sales volume growth in 2026 [24][26] - The company has achieved its carbon emissions reduction goal six years early and continues to prioritize sustainability and environmental stewardship [25] - Management highlighted the importance of product innovation and the recent acquisition of ACI in driving future growth in the HIP segment [22][25][86] Other Important Information - The company announced the planned retirement of its long-serving CFO, Steve Bender, later in 2026 [13][14] - The company maintains a strong balance sheet with $2.9 billion in cash and securities and total debt of $5.6 billion [20][21] Q&A Session Summary Question: Can you break down the PEM business in Q4 and its performance? - Management noted that the beat in PEM was due to proactive steps taken in their three-pillar initiative, including the removal of losses from shuttered assets and cost reduction initiatives [30][32] Question: What are the expectations around polyethylene price increases? - Management indicated some improvement in demand and price action, with announced price increases expected to offset previous market adjustments [33][34] Question: What is the outlook for chlorovinyls and PVC chain in 2026? - Management remains cautiously optimistic, noting some restocking and price improvements, but acknowledges ongoing structural supply issues [38][39] Question: How will the $600 million in cost savings be realized throughout the year? - Management explained that savings from actions taken in 2025 will continue into 2026, with expectations for structural cost reductions and improved reliability [44][46] Question: What is the expected free cash flow for 2026? - Management aims to generate strong cash flows and has reduced capital expenditures for 2026, focusing on driving free cash flow across the business [58][60] Question: How does the company view the competitive landscape and potential tariff impacts? - Management stated that the impact of tariffs has been minimal due to USMCA rules, and they do not foresee significant changes in competition from OxyChem [62][68] Question: What are the opportunities in PVC volume for 2026? - Management expects growth in domestic demand for PVC, driven by construction materials, while also noting a cautious outlook on export volumes [76][78]

Financial Data and Key Metrics Changes - In Q4 2025, Westlake reported a net loss of $33 million, or a loss of $0.25 per share, on sales of $2.5 billion, which was a $5 million lower loss compared to Q3 2025 due to lower average sales prices and sales volumes [12][13] - For the full year 2025, the company reported a net loss of $116 million and EBITDA of $1.1 billion, with total sales of $11.2 billion, reflecting an 8% decline compared to 2024 [13][14] Business Line Data and Key Metrics Changes - The Housing and Infrastructure Products (HIP) segment experienced an 8% decline in sales year-over-year in Q4 2025, primarily due to decreased sales volumes in PVC compounds and exterior building products, although municipal pipe sales volumes remained strong [16][18] - The Performance and Essential Materials (PEM) segment's Q4 EBITDA was $45 million, down from $90 million in Q3 2025, driven by a 5% decline in average sales prices and a 2% decrease in sales volume [17][18] Market Data and Key Metrics Changes - The company noted that global overcapacity in certain products continued to exert downward pressure on sales prices, particularly in the PEM segment, leading to a sharp decline in profitability compared to historical levels [9][19] - The company expects housing starts in 2026 to range between 1.3 million and 1.4 million, with improved home affordability due to lower interest rates [21][22] Company Strategy and Development Direction - Westlake is implementing a three-pillar strategy aimed at achieving $600 million in earnings improvement in 2026 through cost reductions, plant reliability improvements, and footprint optimization [7][10][20] - The company has taken decisive actions to close higher-cost PEM assets and improve operational reliability, which are expected to enhance financial performance in a competitive global marketplace [10][11][24] Management's Comments on Operating Environment and Future Outlook - Management expressed cautious optimism regarding a rebound in demand and sales volume growth in 2026, supported by signs of improvement in global industrial and manufacturing activity [24][25] - The company has achieved its carbon emissions reduction goal six years ahead of schedule, reflecting its commitment to sustainability and environmental stewardship [25] Other Important Information - The company announced that its long-serving CFO, Steve Bender, plans to retire later in 2026, marking a significant transition in leadership [11][12] - Westlake's balance sheet remains strong, with cash and securities totaling $2.9 billion and total debt of $5.6 billion as of December 31, 2025 [19][20] Q&A Session Summary Question: Can you break down the PEM business in Q4 and compare it to previous announcements? - Management noted that the beat was due to proactive steps in their three-pillar initiative, which included removing losses from shuttered assets and initiating cost reduction measures [31][32] Question: What are your expectations around polyethylene price increases? - Management indicated that there has been some improvement in demand and price action, with announced price increases expected to offset previous market adjustments [34] Question: How do you view the chlorovinyls and PVC chain outlook for 2026? - Management remains cautiously optimistic, noting some restocking and price improvements, but acknowledges ongoing structural supply issues [38] Question: Can you clarify the guidance for HIP and its impact on margins? - The guidance reflects expected housing starts similar to 2025, with product mix potentially impacting overall margins [40] Question: What is the expected contribution from the $600 million in cost savings? - Management expects these savings to be realized throughout 2026, driven by actions taken in 2025 and improved operational reliability [44][45] Question: How do you assess the market balance and pricing for caustic soda? - Management reported some price traction in caustic soda, with recent price announcements indicating positive demand signals [97]

Financial Data and Key Metrics Changes - Mativ's full year 2025 net sales were just under $2 billion, up 2.5% organically and modestly on a reported basis compared to the prior year [17] - Adjusted EBITDA for 2025 was $225 million, up 3% year-over-year, with Q4 Adjusted EBITDA increasing 19% to $53.5 million [18][22] - Free cash flow reached a record $94 million in 2025, more than doubling the previous year's result [22][23] Business Line Data and Key Metrics Changes - Filtration and Advanced Materials (FAM) segment net sales were up over 5% year-over-year, with adjusted EBITDA increasing by 26% [19][20] - Sustainable & Adhesive Solutions (SAS) segment sales were largely flat year-over-year on an organic basis, with adjusted EBITDA increasing by more than 8% [20][21] Market Data and Key Metrics Changes - The company faced headwinds in certain markets, particularly in automotive labels and release liners in Europe, impacting the SAS segment [33][49] - Despite challenges, FAM segment showed growth in transportation and industrial filtration, indicating resilience in specific market categories [35][56] Company Strategy and Development Direction - Mativ's strategy focuses on three pillars: enhancing commercial excellence, strengthening the balance sheet, and optimizing the portfolio [6][10] - The company aims to leverage AI as a foundational enterprise capability to drive productivity and operational improvements [15] Management's Comments on Operating Environment and Future Outlook - Management acknowledged a complex macroeconomic environment with dynamic trade movements and geopolitical instability, emphasizing the need for agility [12][28] - For 2026, the company anticipates continued focus on cost-saving initiatives, with expected savings of $15 million to $20 million [27] Other Important Information - Mativ reduced net debt by over $60 million in 2025, ending the year with a net leverage ratio of 4.2 times [23][40] - The company plans to invest $45 million in capital expenditures in 2026, split between growth and efficiency projects [25] Q&A Session Summary Question: Details on headwinds within SAS and potential catalysts for improvement - Management noted weakness in automotive tapes and release liners, but expressed optimism about growth opportunities in other categories and regions [33][34] Question: Sustainability of momentum in FAM segment - Management highlighted ongoing investments and improvements in the FAM segment, expecting continued growth despite market challenges [35][36] Question: Free cash flow expectations for 2026 - Management indicated a small decline in free cash flow from 2025's record levels, primarily due to funding growth initiatives [37][38] Question: Guidance for Q1 and market conditions - Management expects low single-digit volume growth in Q1, with EBITDA growth of 15%-20% despite soft demand [45][52] Question: Commercial pipeline performance relative to market - Management emphasized a focused approach to the commercial pipeline, with strong customer collaboration and improved operational metrics [56]

Financial Data and Key Metrics Changes - The company converted 45% of its EBITDA to free cash flow, which is a higher percentage than many in the industry [8] - The company targeted $100 million in cost savings, achieving an annualized run rate of that amount by the end of 2025, with an expected $45 million in in-year savings for 2026 [21][22] Business Line Data and Key Metrics Changes - The aerospace business is expected to grow slightly better than the build rate, with a focus on wide-body aircraft [17][19] - The company anticipates growth in advanced materials, particularly in the Americas, driven by reindustrialization and recovery in construction [50] Market Data and Key Metrics Changes - Early signs of improved volumes and pricing in Europe were noted, although it is too early to confirm if these increases will fully materialize [9][14] - The company is seeing low inventory levels across the supply chain, which may lead to shortages if demand increases [67] Company Strategy and Development Direction - The company plans to focus on structural changes in operations to generate enough cash to cover dividends and to pursue growth through new product development and innovation [10] - There is an expectation of further opportunities for mergers, joint ventures, and industry consolidation in 2026 [9][26] Management's Comments on Operating Environment and Future Outlook - The management expressed cautious optimism about a gradual recovery in North American home building and durable goods, as well as improvements in the Chinese domestic market [8][11] - The management highlighted the need for European policymakers to take action to improve competitiveness and reduce energy costs [44][55] Other Important Information - The company is selectively using AI tools to reduce costs and expand R&D capabilities [10] - The company has made significant changes in Europe, including headcount reductions and facility closures, to address cost structures [45] Q&A Session Summary Question: What is driving the improvement in Europe? - The management noted price increases across the board and a pickup in construction and auto demand, but remains cautious due to past experiences [14][15] Question: What are the expected cost savings for 2026? - The company expects about $45 million in in-year savings for 2026, following the achievement of a $100 million annualized run rate by the end of 2025 [21][22] Question: What is the outlook for MDI margins? - The management indicated that margins could improve with increased volumes and pricing initiatives, particularly in response to rising costs [36][37] Question: How is the company addressing the potential for industry consolidation? - The management believes there will be opportunities for consolidation, particularly in chaotic market conditions, and is open to exploring strategic actions [26][90] Question: What is the outlook for polyurethanes EBITDA in Q1 2026? - The management indicated that they need to increase prices to offset rising natural gas costs, which are expected to impact EBITDA [94][96]